SCHEMBL7314812

SCHEMBL7314812

COc1ccc(C2(O)c3ccccc3-c3ccccc32)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.48
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.44
PDK2 Q15119 4/20 0.43
MAOA P21397 1/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
PARP1 P09874 1/20 0.39
HCRTR1 O43613 1/20 0.39
CA12 O43570 1/20 0.39
CA4 P22748 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16674125 0.83 ESR1 (0.51) SCN9AALDH1A1LMNAPDK2MAOA
SCHEMBL14970785 0.78 PDK2 (0.36) LMNAPDK2KMT2AMEN1
SCHEMBL17456241 0.78 PDK2 (0.52) ALDH1A1LMNAPDK2GAARAB9A
SCHEMBL7315127 0.77 PDK2 (0.51) SCN9APDK2CA1CA2CA7
SCHEMBL7316250 0.77 KMT2A (0.56) SCN9AALDH1A1PDK2CA1CA2
SCHEMBL21880258 0.77 PDK2 (0.54) PDK2KMT2A
SCHEMBL7315657 0.77 PDK2 (0.51) SCN9AALDH1A1PDK2GAAKMT2A
SCHEMBL15619163 0.76 KMT2A (0.68) SCN9ALMNANPSR1KMT2AMEN1
SCHEMBL19039047 0.75 PDK2 (0.50) ALDH1A1LMNAPDK2CA1CA2
SCHEMBL30281291 0.75 PDK2 (0.50) ALDH1A1LMNAPDK2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 WO disclosed